[HTML][HTML] Personalized management of differentiated thyroid cancer in real life–practical guidance from a multidisciplinary panel of experts
A Campennì, D Barbaro, M Guzzo, F Capoccetti… - Endocrine, 2020 - Springer
Purpose The standard of care for differentiated thyroid carcinoma (DTC) includes surgery,
risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone …
risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone …
[HTML][HTML] False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
D Barbaro, A Campennì, R Forleo, P Lapi - Endocrine, 2023 - Springer
Background and purpose False-positive radioiodine uptake can sometimes be observed
with post-radioiodine treatment (RIT) whole body scanning. Radioiodine pitfall has often …
with post-radioiodine treatment (RIT) whole body scanning. Radioiodine pitfall has often …
New treatment of medullary and papillary human thyroid cancer: biological effects of hyaluronic acid hydrogel loaded with quercetin alone or in combination to an …
V Quagliariello, E Armenia, C Aurilio… - Journal of cellular …, 2016 - Wiley Online Library
The aim of this paper is based on the use of a hyaluronic acid hydrogel of Quercetin tested
alone and in combination to an inhibitor of Aurora Kinase type A and B (SNS‐314) on …
alone and in combination to an inhibitor of Aurora Kinase type A and B (SNS‐314) on …
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer
A Campennì, RM Ruggeri, M Siracusa… - European Journal of …, 2021 - academic.oup.com
Aim The risk of differentiated thyroid cancer (DTC) recurrence is widely evaluated according
to the 2015 ATA Risk Stratification System. Topography of malignant nodules has been …
to the 2015 ATA Risk Stratification System. Topography of malignant nodules has been …
[HTML][HTML] Thyroglobulin value predict iodine-123 imaging result in differentiated thyroid cancer patients
A Campennì, RM Ruggeri, M Siracusa, D Romano… - Cancers, 2023 - mdpi.com
Simple Summary This study was prompted to assess the diagnostic performance of 123I-Dx-
WBS-SPECT/CT in the identification of incomplete structural response in the early follow-up …
WBS-SPECT/CT in the identification of incomplete structural response in the early follow-up …
[HTML][HTML] Dosimetry during adjuvant 131I therapy in patients with differentiated thyroid cancer-clinical implications
P Szumowski, S Abdelrazek, D Iwanicka, M Mojsak… - Scientific Reports, 2021 - nature.com
The activity of radioiodine (131I) used in adjuvant therapy for thyroid cancer ranges between
30 mCi (1.1 GBq) and 150 mCi (5.5 GBq). Dosimetry based on Marinelli's formula, taking …
30 mCi (1.1 GBq) and 150 mCi (5.5 GBq). Dosimetry based on Marinelli's formula, taking …
[HTML][HTML] Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real …
A Campennì, RM Ruggeri, ML Garo, M Siracusa… - Cancers, 2023 - mdpi.com
Simple Summary The aim of the present study was to retrospectively evaluate the efficacy of
low (1.1 GBq) versus moderate (2.2 GBq) 131I activities in a large series (n= 299) of low-risk …
low (1.1 GBq) versus moderate (2.2 GBq) 131I activities in a large series (n= 299) of low-risk …
可疑甲状腺球蛋白增高性分化型甲状腺癌患者经131I 治疗后的临床转归
郭文婷， 慕转转， 李征， 张迎强， 靳晓娜， 林岩松 - 中国癌症杂志, 2022 - china-oncology.com
背景与目的: 分化型甲状腺癌(differentiated thyroid cancer, DTC) 中可疑甲状腺球蛋白(
thyroglobulin, Tg) 水平增高但无明确结构性病灶者预后差异大, 临床治疗决策存在较大争议 …
thyroglobulin, Tg) 水平增高但无明确结构性病灶者预后差异大, 临床治疗决策存在较大争议 …
Theranostics of Thyroid Cancer
Molecular imaging is pivotal in evaluating and managing patients with different thyroid
cancer histotypes. The existing, pathology-based, risk stratification systems can be usefully …
cancer histotypes. The existing, pathology-based, risk stratification systems can be usefully …
[HTML][HTML] Assessment of different radioiodine doses for post-ablation therapy of thyroid remnants: A systematic review
M Ansari, MR Tavirani - Iranian Journal of Pharmaceutical …, 2022 - ncbi.nlm.nih.gov
The determination of radioiodine remnant ablation (RRA) dosage in post-operation thyroid
residual tissues resection has been largely subject of discussion, yet no concise conclusion …
residual tissues resection has been largely subject of discussion, yet no concise conclusion …